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The effect of colloidal silver on the immunological parameters in 
acute intestinal infections 
Polovyan K.S. 
Relevance. At this stage, due to the expansion of the spectrum of bacterial resistance to 
antibiotics, in infectology is used colloidal silver with a particle size of 25 nm as an alternative to 
the traditional treatment of acute intestinal infections. 
The purpose of the study. To study the effect of colloidal silver on the immunological 
parameters in acute intestinal infection caused by opportunistic pathogens. 
Materials and methods. The study involved 50 patients with moderate course of acute 
intestinal infections hospitalized at (1,34±0,08) days from the onset of the disease, mean age 
(37,48±2,76) years. Depending on the regimen, patients were divided into two groups of 25 
people each. Persons in group 1-st received standard treatment – gastric lavage and / or bowel, 
diet, rehydration, enzymes and sorbents, 2-nd – in addition to the basic therapy – colloidal silver 
10 mg/L to 100 ml three times daily for 5 days. Gender, etiology, clinical forms groups were 
comparable. According to the medical history and physical examination the chronic pathology of 
the gastrointestinal tract, hepatobiliary system was deleted. In addition to general clinical tests in 
all patients were examined serum levels of IL-1β, IL-6, IL-4, IL-10 and sIg A at admission and 
(5,73±0,16) day from the onset of the disease. The control group consisted of 20 clinically 
healthy donors. 
Results. At admission in all patients studied cytokine levels were higher than control 
(p<0,001). Thus, the level of IL-1β was (on 1-st, 2-nd and control groups) 4,45±0,48), 
(5,07±0,55) and (1,81±0,03) pg/L; IL-6 – (26,22±1,58), (25,39±1,48) and (1,21±0,16) pg/L; IL-4 
– (8,26±0,52), (9,83±0,37) and (0,97±0,13) pg/L; IL-10 – (17,83±0,28), (18,05±0,41) and 
(0,62±0,13) pg/L. In the dynamics of all convalescents IL-1β decreased to normal and did not 
differ between the groups (p>0,05). The patients in 1-st group IL-6 levels (8,43±0,20), IL-4 
(5,36±0,43) and IL-10 (3,72±0,22) pg/L did not reach rates (p<0,001), but decreased in 
comparison with the acute period of the disease (p<0,001). In patients treated with colloidal 
silver, IL-6 (5,49±0,28), IL-4 (3,95±0,32) and IL-10 (2,02±0,16) pg/L and rapidly decreased 
(p<0,001), but were higher than normal (p<0,001). With coverage in 2-nd group was 
significantly lower than in the 1-st corresponding period of the study (p<0,05-0,001), indicating 
that the smaller local inflammation and reduction of persistent potential pathogens. 
At the beginning of treatment, all patients found knots in sIg A serum to five times 
compared to normal (1-st group – (20,13±1,25) mg/L, 2nd – (20,67±0,95) mg/L and the norm – 
(4,05±0,36) mg/L, p<0,001). In the dynamics of the concentration of sIg A patient treatment 
groups did not reach the control values (p<0,001), but varied depending on the applied treatment 
regimen. The higher levels of sIg A in serum of patients in 1-st group compared with the 2-nd 
(respectively (19,06±1,71) mg/L (13,52±0,90) mg/L, p<0.001), indicating significant 
inflammatory-destructive changes in the intestine and the need to enhance rehabilitation. 
Output. When using colloidal silver in the treatment of acute intestinal infections, 
compared with basic therapy decreases the severity of inflammatory and destructive changes in 
the gastro-intestinal tract. 
